These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 9350175

  • 1. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 2. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 3. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [Abstract] [Full Text] [Related]

  • 4. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Jul; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 5. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R, Ens GE.
    Clin Lab Sci; 1997 Jul; 10(4):219-22. PubMed ID: 10169621
    [Abstract] [Full Text] [Related]

  • 13. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B, Hillarp A, Berntorp E, Dahlbäck B.
    Annu Rev Med; 1997 Jul; 48():45-58. PubMed ID: 9046944
    [Abstract] [Full Text] [Related]

  • 14. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH.
    Nature; 1994 May 05; 369(6475):64-7. PubMed ID: 8164741
    [Abstract] [Full Text] [Related]

  • 15. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K, Dahlbäck B, Nicolaes GA.
    Thromb Haemost; 2007 Sep 05; 98(3):530-42. PubMed ID: 17849041
    [Abstract] [Full Text] [Related]

  • 16. Inherited Thrombophilia due to Factor V Leiden Mutation.
    Mattson JC, Crisan D.
    Mol Diagn; 1998 Mar 05; 3(1):55-61. PubMed ID: 10096958
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B, Holm J, Svensson P, Dahlbäck B.
    Thromb Haemost; 1996 Feb 05; 75(2):270-4. PubMed ID: 8815575
    [Abstract] [Full Text] [Related]

  • 18. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
    Dahlbäck B, Villoutreix BO.
    Arterioscler Thromb Vasc Biol; 2005 Jul 05; 25(7):1311-20. PubMed ID: 15860736
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ, Zöller B, Dahlbäck B.
    Thromb Haemost; 1997 Feb 05; 77(2):332-5. PubMed ID: 9157592
    [Abstract] [Full Text] [Related]

  • 20. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z, Seligsohn U, Zivelin A, Eldor A.
    Harefuah; 1995 Jul 05; 129(1-2):1-5, 80. PubMed ID: 7557699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.